A detailed history of Probity Advisors, Inc. transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Probity Advisors, Inc. holds 1,902 shares of SWAV stock, worth $0. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,902
Previous 1,873 1.55%
Holding current value
$0
Previous $356,000 73.88%
% of portfolio
0.13%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$191.17 - $325.63 $5,543 - $9,443
29 Added 1.55%
1,902 $619,000
Q4 2023

Feb 12, 2024

BUY
$160.99 - $215.69 $7,405 - $9,921
46 Added 2.52%
1,873 $356,000
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $5,246 - $7,667
27 Added 1.5%
1,827 $363,000
Q2 2023

Aug 10, 2023

SELL
$223.05 - $302.68 $9,145 - $12,409
-41 Reduced 2.23%
1,800 $513,000
Q4 2022

Feb 14, 2023

BUY
$204.38 - $296.82 $2,043 - $2,968
10 Added 0.55%
1,841 $378,000
Q3 2022

Nov 14, 2022

SELL
$195.21 - $310.53 $4,489 - $7,142
-23 Reduced 1.24%
1,831 $509,000
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $5,679 - $10,509
-49 Reduced 2.57%
1,854 $354,000
Q1 2022

May 10, 2022

SELL
$127.96 - $207.36 $383 - $622
-3 Reduced 0.16%
1,903 $395,000
Q4 2021

Feb 10, 2022

SELL
$165.13 - $241.83 $990 - $1,450
-6 Reduced 0.31%
1,906 $340,000
Q3 2021

Oct 08, 2021

BUY
$163.99 - $235.57 $3,115 - $4,475
19 Added 1.0%
1,912 $394,000
Q2 2021

Aug 06, 2021

SELL
$131.45 - $201.49 $8,281 - $12,693
-63 Reduced 3.22%
1,893 $359,000
Q1 2021

Apr 28, 2021

BUY
$92.73 - $142.05 $181,379 - $277,849
1,956 New
1,956 $255,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Probity Advisors, Inc. Portfolio

Follow Probity Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Probity Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Probity Advisors, Inc. with notifications on news.